Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis
Authors:
- L. KabbashLKL. Kabbash
- Y. TurenneYTY. Turenne
- M. PrevostMPM. Prevost
- J. HebertJHJ. Hebert
- P.M. BedardPBP.M. Bedard
- M. NedilskiMNM. Nedilski
- A. GutkowskiAGA. Gutkowski
- J. SchulzJSJ. Schulz
- 1 November 1989
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 84 (5) , 741-746
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Pharmacologic evaluation of loratadine (SCH 29851), chlorpheniramine and placeboEuropean Journal of Clinical Pharmacology, 1986
- Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamineInflammation Research, 1984